SP1 can regulate gene FE65, which act as a ligand of Alzheimer’s disease amyloid precursor protein, and SP1 can promote the expression of SNAP-25, which is involved in the pathogenesis of neuropsychiatric disorders, including schizophrenia, attention deficit hyperactivity disorder and AD [19–21]. This evidence concerns the gene SNAP25 and attention deficit-hyperactivity disorder.